Naoyuki Harada1, Kosuke Kondo1, Sayaka Terazono1, Kei Uchino1, Yutaka Fuchinoue1, Nobuo Sugo2. 1. Department of Neurosurgery (Omori), Faculty of Medicine, School of Medicine, Toho University, 6-11-1, Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan. 2. Department of Neurosurgery (Omori), Faculty of Medicine, School of Medicine, Toho University, 6-11-1, Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan. nsugo@med.toho-u.ac.jp.
Abstract
BACKGROUND: N-isopropyl- (123I) p-iodoamphetamine (123I-IMP) is specifically accumulated in primary central nervous system lymphoma (PCNSL) during single-photon emission tomography (SPECT) and contributes to its diagnostic imaging. However, whether 123I-IMP is accumulated in ocular adnexal lymphoma (OAL), one of the malignant intraorbital tumors, remains unclear. This study aimed to evaluate the diagnostic value of 123I-IMP SPECT in OAL. METHODS: Between August 2005 and June 2020, 26 patients with intraorbital tumors underwent neurosurgery at the tertiary care center. Of these, 15 patients who underwent 123I-IMPSPECT before surgery were retrospectively examined. The region of interest was set in the cerebellum ipsilateral to the intraorbital tumor on 123I-IMP SPECT, and the tumor-to-cerebellum ratio (T/C ratio) was calculated using the following formula: T/C ratio = [accumulation of tumor (count/pixel)]/[accumulation of ipsilateral normal cerebellar hemisphere (count/pixel)]. RESULTS: Six patients were included in the OAL group, who were pathologically diagnosed with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), diffuse large B-cell lymphoma (DLBCL), and plasmacytoma. The T/C ratio in the OAL group was statistically higher than that in the non-OAL group (p < 0.01). The optimal cutoff values for both groups were between 0.76 and < 0.93. The sensitivity and specificity were 1.00, respectively. CONCLUSIONS: 123I-IMP SPECT is useful as one of the examinations in the differential diagnoses of OAL, because it showed a significantly higher accumulation in OAL group than in non-OAL group.
BACKGROUND: N-isopropyl- (123I) p-iodoamphetamine (123I-IMP) is specifically accumulated in primary central nervous system lymphoma (PCNSL) during single-photon emission tomography (SPECT) and contributes to its diagnostic imaging. However, whether 123I-IMP is accumulated in ocular adnexal lymphoma (OAL), one of the malignant intraorbital tumors, remains unclear. This study aimed to evaluate the diagnostic value of 123I-IMP SPECT in OAL. METHODS: Between August 2005 and June 2020, 26 patients with intraorbital tumors underwent neurosurgery at the tertiary care center. Of these, 15 patients who underwent 123I-IMPSPECT before surgery were retrospectively examined. The region of interest was set in the cerebellum ipsilateral to the intraorbital tumor on 123I-IMP SPECT, and the tumor-to-cerebellum ratio (T/C ratio) was calculated using the following formula: T/C ratio = [accumulation of tumor (count/pixel)]/[accumulation of ipsilateral normal cerebellar hemisphere (count/pixel)]. RESULTS: Six patients were included in the OAL group, who were pathologically diagnosed with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), diffuse large B-cell lymphoma (DLBCL), and plasmacytoma. The T/C ratio in the OAL group was statistically higher than that in the non-OAL group (p < 0.01). The optimal cutoff values for both groups were between 0.76 and < 0.93. The sensitivity and specificity were 1.00, respectively. CONCLUSIONS: 123I-IMP SPECT is useful as one of the examinations in the differential diagnoses of OAL, because it showed a significantly higher accumulation in OAL group than in non-OAL group.
Authors: Qi Yong H Ai; Huimin Zhang; Baiyan Jiang; Tiffany Y So; Frankie K F Mo; Sahrish Qamar; Weitian Chen; Ann D King Journal: Eur J Radiol Date: 2020-12-24 Impact factor: 3.528
Authors: Y Akiyama; K Moritake; T Yamasaki; Y Kimura; A Kaneko; Y Yamamoto; T Miyazaki; M Daisu Journal: J Nucl Med Date: 2000-11 Impact factor: 10.057
Authors: D E Kuhl; J R Barrio; S C Huang; C Selin; R F Ackermann; J L Lear; J L Wu; T H Lin; M E Phelps Journal: J Nucl Med Date: 1982-03 Impact factor: 10.057
Authors: Maria S Kalemaki; Apostolos H Karantanas; Dimitris Exarchos; Efstathios T Detorakis; Odysseas Zoras; Kostas Marias; Corina Millo; Ulas Bagci; Ioannis Pallikaris; Andreas Stratis; Ioannis Karatzanis; Kostas Perisinakis; Pavlos Koutentakis; Georgios A Kontadakis; Demetrios A Spandidos; Aristidis Tsatsakis; Georgios Z Papadakis Journal: Int J Oncol Date: 2020-01-03 Impact factor: 5.650